Author: Unknown
Published on: 31/07/2025 | 00:00:00
AI Summary:
French scientists are experimenting with a new way to combat Parkinson's disease. The trial is still at a very early stage, but could lead to breakthroughs in the treatment of the neurodegenerative disease, researchers say. Around 10 million people worldwide have Parkinson’s, and that figure is expected to double by 2050. French clinical trial could help slow the disease and alleviate symptoms. It targets dopamine-secreting neurons, which are critically affected as Parkinson's progresses. The aim of the trial is to slow down patients' neurological deterioration.
Original: 391 words
Summary: 85 words
Percent reduction: 78.26%
I'm a bot and I'm open source